Loading...
Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
A great challenge in multi-targeting drug discovery is to identify drug-like lead compounds with therapeutic advantages over single target inhibitors and drug combinations. Inspired by our previous efforts in designing antitumor evodiamine derivatives, herein selective histone deacetylase 1 (HDAC1)...
Saved in:
| Published in: | Acta Pharm Sin B |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Elsevier
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7452071/ https://ncbi.nlm.nih.gov/pubmed/32874829 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.apsb.2019.11.011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|